TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
MRVI

Maravai Lifesciences Holdings Inc

Healthcare · Biotechnology

7.40$ -1.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement MRVI
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
49.1% 46.7% 28.0% 17.6% 19.1% 51.5% 58.2% 82.0%
50.9% 53.3% 72.0% 82.4% 80.9% 48.5% 41.8% 18.0%
3.6% 2.5% 3.3% 1.9% 2.1% 6.0% 7.4% 12.6%
33.3% 33.8% 33.2% 12.5% 14.6% 52.0% 62.4% 78.1%
36.9% 36.5% 29.8% 13.0% 15.8% 59.5% 132.7% 21.6%
13.3% 16.8% 42.2% 69.4% 65.0% -11.0% -90.9% -3.6%
22.1% 20.9% 10.8% 3.8% 2.3% 15.9% 18.4% 14.5%
-13.3% -4.1% 28.8% 66.4% 62.5% 213.8% -100.9% -126.5%
0.3% -0.5% 1.0% 7.7% 6.9% 261.7% -0.7% -2.3%
-14.3% -5.9% 27.1% 22.8% 24.9% -41.2% -55.9% -70.4%
26.8% 33.7% 48.7% 73.3% 69.1% 246.6% -60.5% -79.2%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?